City of Hope scientists have combined two potent immunotherapies—an oncolytic virus and chimeric antigen receptor (CAR) T cell therapy—to target
Read moreHome »
solid
Adoptive T-cell therapy ADP-A2M4 targeting MAGE-A4 shows early activity in patients with advanced solid tumors
The adoptive T-cell therapy ADP-A2M4, which is engineered to express a T-cell receptor (TCR) directed against the MAGE-A4 cancer antigen,
Read more